All In Biotech

Drug Trial Radar · NCT05782881

High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program

High Risk Population of Cardiovascular Disease in Hubei Province (Coronary Heart Disease With Diabetes) Screening and Intervention Program

Last checked: Nov 19, 2026Latest source record: Dec 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 16,000 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

16,000

Planned (sponsor's estimate)

Start

Jan 15, 2023

Primary completion

Dec 31, 2023

Study completion Dec 31, 2024

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Peking University First Hospital
First posted
Mar 24, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

High Risk Population of Cardiovascular Disease in Hubei Province (Coronary Heart Disease With Diabetes) Screening and Intervention Program(CCDInT)is a randomized controlled study to verify that protocol treatment group is more effective than the conventional treatment group in reducing the incidence of composite cardiovascular disease (cardiovascular death, non fatal myocardial infarction, non fatal stroke, hospitalization for heart failure, and readmission for acute coronary syndrome) in patients with coronary heart disease and type 2 diabetes.

Conditions

  • Cardiovascular Diseases
  • Diabetes Mellitus, Type 2
  • Coronary Disease

Interventions

  • phone calls and encouraging patients' lifestyle change and medication adherenceBehavioral

    Use some methods to strictly intervene blood glucose , blood pressure and blood lipids for protocol treatment group people.

  • StatinDrug

    Treatment and management according to the guidelines

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite cardiovascular disease (cardiovascular death, non fatal myocardial infarction, non fatal stroke, hospitalization for heart failure, and readmission for acute coronary syndrome)Time frame: 1 year after baseline

Locations

107 sites in 1 country. Site status is shown where the registry gives one.

  • Affiliated Minzu University Hospital of Hubei Minzu University

    Enshi, Hubei, China · Not yet recruiting

  • Badong Peolple's Hospital

    Enshi, Hubei, China · Not yet recruiting

  • Enshi Central Hospital

    Enshi, Hubei, China · Not yet recruiting

  • Laifeng People's Hospital

    Enshi, Hubei, China · Not yet recruiting

  • Lichuan People's Hospital

    Enshi, Hubei, China · Not yet recruiting

  • The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture

    Enshi, Hubei, China · Not yet recruiting

  • The People's Hospital of Jianshi

    Enshi, Hubei, China · Not yet recruiting

  • Xianfeng County People's Hospital

    Enshi, Hubei, China · Not yet recruiting

  • Xuanen People's Hospital

    Enshi, Hubei, China · Not yet recruiting

  • Ezhou Central Hospital

    Ezhou, Hubei, China · Not yet recruiting

  • Ezhou Hospital of Chinese Medicine

    Ezhou, Hubei, China · Not yet recruiting

  • Hongan People's Hospital

    Huanggang, Hubei, China · Not yet recruiting

  • Huangmei Peolple's Hospital

    Huanggang, Hubei, China · Not yet recruiting

  • Luotian People's Hospital

    Huanggang, Hubei, China · Not yet recruiting

  • People's Hostpital of Macheng City

    Huanggang, Hubei, China · Not yet recruiting

  • Qichun People's Hospital

    Huanggang, Hubei, China · Not yet recruiting

  • The People's Hospital of Tuanfeng

    Huanggang, Hubei, China · Not yet recruiting

  • Wuxue People's Hopital

    Huanggang, Hubei, China · Not yet recruiting

  • Xishui People's Hospital

    Huanggang, Hubei, China · Not yet recruiting

  • Yingshan People's Hospital

    Huanggang, Hubei, China · Not yet recruiting

  • Daye People's Hospital

    Huangshi, Hubei, China · Not yet recruiting

  • Huangshi Central Hospital

    Huangshi, Hubei, China · Not yet recruiting

  • Huangshi Love&Health Hospital Affiliated of Hubei Polytechnic University

    Huangshi, Hubei, China · Not yet recruiting

  • Yangxin People's Hospital

    Huangshi, Hubei, China · Not yet recruiting

  • Jingmen NO.1 People's Hospital

    Jingmen, Hubei, China · Not yet recruiting

  • Jingmen NO.2 People's Hospital

    Jingmen, Hubei, China · Not yet recruiting

  • Jingshan Union Hospital of Huazhong University of Science and Technology

    Jingmen, Hubei, China · Not yet recruiting

  • Zhongxiang Hospital of Traditional Chinese Medicine

    Jingmen, Hubei, China · Not yet recruiting

  • Zhongxiang People's Hospital

    Jingmen, Hubei, China · Not yet recruiting

  • Chinese Medicine Hospital of Gongan

    Jingzhou, Hubei, China · Not yet recruiting

  • Chinese Medicine Hospital of Honghu

    Jingzhou, Hubei, China · Not yet recruiting

  • Jiangling People's Hospital

    Jingzhou, Hubei, China · Not yet recruiting

  • Jianli Hospital of Chinese Medicine

    Jingzhou, Hubei, China · Not yet recruiting

  • Jianli People's Hospital

    Jingzhou, Hubei, China · Not yet recruiting

  • Jingzhou Central Hospital

    Jingzhou, Hubei, China · Not yet recruiting

  • Jingzhou Hospital of Traditional Chinese Medicine

    Jingzhou, Hubei, China · Not yet recruiting

  • Jingzhou No.1 People's Hospital

    Jingzhou, Hubei, China · Not yet recruiting

  • People's Hospital of Gongan

    Jingzhou, Hubei, China · Not yet recruiting

  • People's Hospital of Honghu

    Jingzhou, Hubei, China · Not yet recruiting

  • Shishou People's Hostpital

    Jingzhou, Hubei, China · Not yet recruiting

Showing 40 of 107 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.